Pharmaceutical Executive
Company-commissioned report exonerates senior managers, points fingers at sales team
Pharmaceutical Executive-09-13-2006
Pharmaceutical Executive
Drug makers used aggressive contracting to retain marketshare after launch of generic simvastatin
Pharmaceutical Executive
Pricing, marketing cases expected to escalate in the future
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
